12 Oct 20230 Comments
Two vaccinations against respiratory syncytial virus (RSV) are now available. The common and contagious virus infects the respiratory tract, and can cause such symptoms as a runny nose, coughing, sneezing, wheezing and fever. But RSV can evolve into more serious conditions like pneumonia, especially in those over 65 and the immunocompromised, says Dr. Sean Cloonan, infectious disease physician at Scarsdale Medical Group, an affiliate of White Plains Hospital.
The new vaccines, made by GSK and Pfizer, work by causing an immune response that can protect you from respiratory disease if you are infected with RSV in the future. Each dose provides protection for at least two winter seasons, according to the CDC.